Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Argus Health
Queensland Health
Deloitte
Harvard Business School
Chinese Patent Office
Johnson and Johnson
McKesson
Cantor Fitzgerald

Generated: February 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,935,690

« Back to Dashboard

Which drugs does patent 7,935,690 protect, and when does it expire?

Patent 7,935,690 protects TESTIM and is included in one NDA.

This patent has forty-five patent family members in twenty-nine countries.
Summary for Patent: 7,935,690
Title:Pharmaceutical composition
Abstract: A pharmaceutical composition comprising: (A) an androgen; (B) a cyclic enhancer of the type used in the compositions and methods claimed by U.S. Pat. No. 5,023,252 to Hsieh; and (C) a thickening agent; including, for example, a composition in which the cyclic enhancer is a macrocyclic ester or a macrocyclic ketone; the use of the composition to treat a condition, for example, male hypogonadism, in a patient by applying the composition to the membrane of the patient; and a method for making the composition.
Inventor(s): Gyurik; Robert J. (Exeter, NH)
Assignee: CPEX Pharmaceuticals, Inc. (Exeter, NH)
Application Number:11/928,467
Patent Claim Types:
see list of patent claims
Use; Composition; Delivery;

Drugs Protected by US Patent 7,935,690

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Auxilium Pharms Llc TESTIM testosterone GEL;TRANSDERMAL 021454-001 Oct 31, 2002 AB2 RX Yes Yes ➤ Sign Up ➤ Sign Up METHOD FOR ADMINISTRATION OF TESTOSTERONE ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 7,935,690

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,320,968 Pharmaceutical composition ➤ Sign Up
7,608,607 Pharmaceutical composition ➤ Sign Up
8,178,518 Pharmaceutical composition ➤ Sign Up
7,608,608 Pharmaceutical composition ➤ Sign Up
7,608,610 Pharmaceutical composition ➤ Sign Up
8,063,029 Pharmaceutical composition ➤ Sign Up
7,608,609 Pharmaceutical composition ➤ Sign Up
7,608,605 Pharmaceutical composition ➤ Sign Up
7,608,606 Pharmaceutical composition ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 7,935,690

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Taiwan I362932 ➤ Sign Up
Taiwan 200408397 ➤ Sign Up
Saudi Arabia 1707 ➤ Sign Up
Poland 213976 ➤ Sign Up
Poland 372083 ➤ Sign Up
New Zealand 535970 ➤ Sign Up
Norway 335864 ➤ Sign Up
Norway 20045019 ➤ Sign Up
Malaysia 139721 ➤ Sign Up
Mexico PA04010311 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Deloitte
Fuji
Colorcon
AstraZeneca
Express Scripts
Mallinckrodt
Julphar
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot